hotspot -WSS

hotspot

author：comprehensive 2025-08-31 21:00:59 - browse：39

An illustrated portrait of Eli Lilly's David Ricks and Skovronsky – biotech and pharma coverage from STAT — Eli Lilly CEO David Ricks (left) and Chief Scientific Officer Daniel S. Skovronsky Molly Ferguson for STAT

The partnership that would shape Eli Lilly into one of the biggest success stories in the pharmaceutical industry began with conversations around a relatively minor acquisition.

At the time, David Ricks was running Lilly’s U.S. business and was part of the team charged with evaluating Avid Radiopharmaceuticals, which Lilly would go on to purchase in 2010 for a paltry $300 million — couch change for a multibillion-dollar firm. But what struck Ricks was not the company’s technology, for imaging Alzheimer’s plaques, but Avid’s CEO, Daniel S. Skovronsky.

“Dan’s different,” Ricks told STAT. “I had this sense immediately. Some people get in biotech for the cha-ching.” Skovronsky turned out to be a secret weapon. Within six months, Ricks had been promoted to run Lilly’s biomedicine unit and Skovronsky was working for him.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Report captures long Covid’s disabling effects and policy challenges

WSS

Cosmetics set for new safety regulation. Why the industry is on board

Stephen Quake on the Chan Zuckerberg quest to conquer disease

Curing rare childhood diseases will falter unless Congress steps up

Deposition: Sackler embraced plan to conceal OxyContin’s strength

Doctors find melanoma drugs effective against rare brain cancer

5 takeaways from STAT's examination of Zynex Medical

explore

hotspot

leisure time

BioMarin wins approval for gene therapy to treat hemophilia A

'Essentially witchcraft:' A former naturopath takes on the field

Anesthesiologist group: stop taking Ozempic before surgery

5 takeaways from STAT's examination of Zynex Medical

Alkermes shareholders re

Heat wave can put hearts into ‘oxygen debt,' lab experiment shows

23andMe had bad news about my health. I wish a person had delivered it

Custom gene therapy hints at new path for rare disease treatments

Anesthesiologist group: stop taking Ozempic before surgery

Coercive sterilizations revealed by STAT prompt outrage

leisure time

Heat wave can put hearts into ‘oxygen debt,' lab experiment shows

STAT Virtual Event: The State of Biosimilars: What to Watch

Curing rare childhood diseases will falter unless Congress steps up

Deposition: Sackler embraced plan to conceal OxyContin’s strength

Rescued Australian man who was adrift 3 months in Pacific with dog 'grateful' to be alive

Medicare to cover more brain scans for Alzheimer’s patients

hotspot

Wikipedia

hotspot

focus